Covid-19 study pauses at J&J, Lilly could be hard bumps — or mere blips
Experts stress that clinical trial pauses are common — and even signs that the system is working as it should.
"To clinical trial experts, these pauses are heartening, a sign that the scientists in charge are prioritizing the safety of volunteers and future patients — that the system is working."
With 2 #Covid19 vaccine trials & Eli Lilly's monoclonal antibody trial on pause, it might be tempting to think pessimistic thoughts. But this is the way clinical trials are supposed to work. Bump in the road or something more? Too soon to know.
In just over a month, we've seen pauses in three #Covid19 studies — two vaccine trials & one monoclonal antibody trial. What should you make of these halts? Smart analysis from
Covid-19 study pauses at J&J, Lilly could be hard bumps — or mere blips,
chadi nabhan MD, MBA, FACP
Developing vaccines & treatments against #COVID19 continues to be challenging as